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Table 2
Pre-Radiographic Lesions at the 12-Month Visit and 12-to-48 Month Incident TF Cartilage Damage (upper portion of table) and 12-to-48 Month Incident PF Cartilage
Damage (lower portion of table). The table shows the frequency of knees with incident cartilage damage among knees without andwith each lesion and the lesion present vs.
absent adjusted odds ratio (OR) and associated 95% conﬁdence interval (Cl) for incident TF cartilage damage. Signiﬁcant results are shown in bold italics. (TF¼ tibiofemoral; PF
¼ patellofemoral)
Number of knees without TF
cartilage damage at the 12- month
visit (457 knees from 457 persons
with both knees K/L 0)
Number of knees (row%) with
incident TF cartilage damage
OR (95% CI) adjusted for age, gender, BMI,
previous knee injury, previous knee surgery,
hand OA, physical activity
Bone marrow lesion, TF or PF or both
No bone marrow lesion (TF or PF)
234 30 (12.8%) 1.83 (0.94, 3,57)*
223 15 (6.7%) reference
Bone marrow lesion, any TF No TF
bone marrow lesion
64 8 (12.5%) 1.38 (0.60, 3.17)y
393 37 (9.4%) reference
Meniseal tearx,k No meniscal tear 56 6 (10.7%) 1.05 (0.39, 2.82)z
401 39 (9.7%) reference
Meniscal extrusionx No meniscal
extrusion
37 6 (16.2%) 1.72 (0.63, 4.71)z
420 39 (9.3%) reference
Number of knees without PF cartilage
damage at the 12- month visit
(322 knees from 322 persons with
both knees K/L 0)
Number of knees (row%) with
incident PF cartilage damage
OR (95% CI) adjusted for age, gender, BMI,
previous knee injury, previous knee surgery,
hand OA, physical activity
Bone marrow lesion, TF or PF or
both No bone marrow lesion
(TF or PF)
94 18 (19.2%) 2.68 (1.32, 543)
228 19 (8,3%) reference
Bone marrow lesion, any PF No
PF bone marrow lesion
52 14 (26.9%) 4.26 (1.97, 9.22)
270 23 (8.5%) reference
*hand OA also signiﬁcant in this model, adjusted OR 2.07 (1.02, 4.19).
yhand OA also signiﬁcant in this model, adjusted OR 2.09 (1.04, 4.20).
zhand OA also signiﬁcant in this mode), adjusted OR 2.03 (1.004, 4.10).
xTo adjust for the presence of the other meniscal lesion, meniscal tear and meniscal extrusion were included in the same model.
kOf the 56 meniscal tears, 43 were horizontal tears, 8 were vertical, 1 was complex, and 4 menisci were partially macerated.
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niﬁcance by testing the hypotheses: cartilage damage, bone marrow
lesions, and meniscal damage are associated with incident persistent
symptoms; bone marrow lesions and meniscal damage are associated
with incident tibiofemoral cartilage damage; bone marrow lesions are
associated with incident patellofemoral cartilage damage.
Methods: In a cohort study of 849 OAI (Osteoarthritis Initiative) par-
ticipants who were Kellgren and Lawrence grade 0 in both knees, we
assessed right knee (left if right technically inadequate) cartilage, bone
marrow lesions, andmeniscal damage on 12-monthMRIs usingMOAKS,
as well as, in those at risk for each outcome, incident persistent symp-
toms (frequent knee symptoms or medication use for knee symptoms
most days of amonth in the past 12months, at 2 consecutive annual OAI
visits) by 5-year follow-up, and incident tibiofemoral cartilage damage
and incident patellofemoral cartilage damage by 4-year follow-up.
Multiple logistic regression (one knee/person) was used to evaluate
associations betweenMRI lesions and each of these outcomes, adjusting
for age, gender, BMI, knee injury, and knee surgery, (and, in cartilage
damage models, further adjusting for hand OA and physical activity).
Results: 76% had cartilage damage, 61% had bone marrow lesions, 21%
meniscal tears, and 14% meniscal extrusion. As shown in Table 1, in 573
knees (from 573 persons) at risk, cartilage damage (isolated patellofe-
moral; tibiofemoral and patellofemoral), bone marrow lesions (any;
isolated patellofemoral; tibiofemoral and patellofemoral), meniscal
tears, and BMI were associated with incident persistent symptoms. As
shown in Table 2, in 457 knees at risk, hand OA but no individual lesion
type was associated with incident tibiofemoral cartilage damage, and,
in 322 knees at risk, bone marrow lesions (any; any patellofemoral)
with incident patellofemoral damage. Having more lesion types was
associated with a greater risk of outcomes.
Conclusions: In persons at higher risk but without any evidence of
radiographic knee OA, cartilage damage, bone marrow lesions, and
meniscal tears were associated with the new development of persistent
symptoms, and bone marrow lesions with the new development of
patellofemoral cartilage damage. These ﬁndings suggest that these
lesions are not incidental in persons at higher risk and may represent
early disease and illness.81
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EFFECT ON PROGRESSION OF MRI FEATURES AND KNEE PAIN
M.L. Landsmeer y, J. Runhaar y, P. van der Plas z, M. van Middelkoop y,
M. Reijman x, B. Koes y, P. Bindels y, E.H. Oei x, S.M. Bierma-Zeinstra k.
yDept. of Gen. Practice, Erasmus MC, Univ. Med. Ctr., Rotterdam,
Netherlands; zDept. of Radiology, Maasstad Hosp., Rotterdam,
Netherlands; xDept. of Orthopaedics, Erasmus MC, Univ. Med. Ctr.,
Rotterdam, Netherlands; kDept. of Gen. Practice, Dept. of Orthopaedics,
Erasmus MC, Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: The preventive effect of a diet & exercise program and of oral
glucosamine sulphate on the primary outcome ‘clinical and radio-
graphic knee osteoarthritis (OA)’ in the PROOF study was borderline
signiﬁcant. Is it unknown what the effect is on the more sensitive sec-
ondary outcome ‘progression of OA-features on magnetic resonance
imaging (MRI)’ and if such outcome is related with incident chronic
knee pain. The aim of this study is to evaluate the preventive effects of
the PROOF study on progression of MRI OA-features and to evaluate the
association between progression of MRI OA-features and incident
chronic knee pain.
Methods: In a 2x2 factorial design, the effects of a diet and exercise
program (DEP) versus no intervention (DEP control) and of double-
blind glucosamine sulphate (GS) versus placebo on the progression of
MRI OA-features, were evaluated over 2.5 years in a high-risk group of
407 middle-aged womenwith a BMI  27 kg/m 2 and without knee OA
during initial screening (PROOF study, ISRCTN 2823086). MRIs were
scored using theMRI Osteoarthritis Knee Score (MOAKS). Progression of
MRI OA-features was deﬁned as progression of bone marrow lesions,
cartilage loss, osteophytes or meniscus pathology (extrusion and mor-
phologic change). Intention To Treat (ITT) and Per Protocol (PP) analysis
for those compliant to DEP were performed on knee level using
adjusted Generalized Estimating Equations. The same statistical model
was used for the analysis between progression of MRI OA-features and
incident chronic knee pain, deﬁned as pain in the last 12 months and on
most days of the previous month. Due to a known interaction between
the two interventions (DEP and GS) on the primary outcome, the 3
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separately with the DEP control þ placebo group as reference group.
Results: 687 knees of 347 women with mean age 55.7 years ( 3.2 SD)
and mean BMI 32.3kg/m2 (4.2 SD) had baseline and follow-up MRI
available for analysis. There was no selective drop-out and the women
were equally distributed over the 4 groups. ITT analysis showed a sig-
niﬁcant preventive effect in the DEP þ placebo group on overall pro-
gression of meniscus pathology (OR 0.61, 95% CI [0.38 - 0.99], p-value
(p) 0.046). PP analysis showed a signiﬁcant preventive effect in the DEP
þ placebo group on overall progression of meniscus pathology (OR 0.43,
95% CI [0.22 - 0.84], p 0.014) and on overall progression of bone marrow
lesions (OR 0.26, 95% CI [0.08 - 0.88], p 0.030). The 2 other groups (DEP
þGS and DEP controlþGS) showed no signiﬁcant effects on overall MRI
OA-features. When differentiated according to location in the knee, all
effects were seen in the medial meniscus or at the medial tibio-femoral
compartment. (ITT: medial meniscus extrusion: OR 0.47, 95% CI [0.24 -
0.91], p 0.025; medial bone marrow lesion: OR 0.33, 95% CI [0.14 -0.77],
p 0.011, PP: medial bone marrow lesion: OR 0.13, 95% CI [0.02 - 0.93], p
0.042). Evaluating the effects of the MRI OA-features on pain, 42 of 347
women (12%) met the deﬁnition of incident chronic knee pain in one or
both knees (52 of 687 knees (6.7%)). Progression of bonemarrow lesions
was signiﬁcant associated with incident chronic knee pain (OR 2.1, 95%
CI [1.02 - 4.46]).
Conclusions: A diet and exercise program has preventive effects on
progression of meniscus pathology and on bonemarrow lesions seen on
MRI. Progression of bone marrow lesions is associated with incident
chronic knee pain.
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J. Stefanik y, K. Gross z, D. Felson y, J. Niu y, Y. Zhang y, C. Lewis x,
N. Segal k, M. Nevitt{, F. Roemer#, A. Guermazi y, T. Neogi y. yBoston
Univ., Boston, MA, USA; zMGH Inst. of Hlth.Professions, Boston, MA, USA;
xUniv. of Alabama, Birmingham, AL, USA; kUniv. of Iowa, Iowa City, IA,
USA; {UCSF, San Francisco, CA, USA; #Klinikum Augsburg, Augsburg,
Germany
Purpose: Contrary to the expectations of biomechanical models, we
previously demonstrated a high prevalence of MRI detected cartilageTable 1
Relative odds of knee pain in knees with MRI-detected structural damage in the medial
Full-thickness cartilage loss [WORMS¼ 2.5, 5 or 6)
MOST (n¼1138) n of painful knees/ N of knees (%) Adjusted OR* (9
None 362/691 (52.4) Reference
Isolated Medial 97/196 (49.5) 0.7 (0.5-1.0)
Isolated Lateral 89/133 (66.9) 1.8 (1.2-2.8)
Mixed 82/118 (69.5) 1.7 (1.1-2.7)
FOA (n[949)
None 229/699 (32.8) Reference
Isolated Medial 54/128 (42.2) 1.2(0.8-1.8)
Isolated Lateral 24/49 (49.0) 1.6 (0.9-3.0)
Mixed 38/73 (52.1) 1.8 (1.1-3.1)
*Adjusted for age, sex, BMI, depressive symptoms and TFJ cartilage loss **Adjusted for T
Table 2
Difference of knee pain severity scores in knees with MRI-detected structural damage in
Full-thickness cartilage loss* (WORMS 2.5, 5 or 6)
40th Percentile# 50th Percentile# 60th Perc
None (Reference) 0 0 0
Isolated Medial 0 (-0.4-0.4) -0.3 (-1.3-0.8) -1.1 (-2.8
Isolated Lateral 4.0 (1.5-6.5) 5.3 (2.0-8.6) 5.8 (2.7-9
Mixed 5.0 (2.9-7.1) 4.1 (1.2-6.9) 4.7 (0.6-8
*Adjusted for age, sex, BMI, depressive symptoms and TFJ cartilage loss.
**Adjusted for TFJ BMLs instead of cartilage loss.
#Difference in VAS pain score (95% CI);Note: Quantile regression results are shown for the
other percentile categories.loss in the medial patellofemoral joint (PFJ), both in unselected pop-
ulations of older adults, and in selected populations at high risk of knee
OA. However, it is unclear whether medial PFJ cartilage damage, though
highly prevalent in older adults, contributes to knee pain. Given that
cartilage is aneural, pain is expected only when full-thickness cartilage
loss and/or bone marrow lesions (BMLs) are present. We therefore
examined the relationship of MRI-detected full-thickness cartilage loss
and BMLs in the medial and lateral PFJ with the presence and severity of
knee pain in two large cohorts of older adults.
Methods: The Multicenter OA (MOST) Study cohort consists of older
adults that have or are at risk of knee OA. The Framingham OA (FOA)
cohort is a sample of the general population of older adults, unselected
for pain or OA, living in Framingham, MA. In both NIH-funded studies,
MRIs were read for cartilage loss and BMLs using Whole Organ MRI
Scores (WORMS). Full-thickness cartilage loss was identiﬁed byWORMS
2.5, 5, or 6, while any size BMLs were identiﬁed byWORMS>0. For each
of these two types of structural damage,we identiﬁed the PFJ region(s) in
which damagewas present as: none, isolatedmedial, isolated lateral and
mixed (both medial and lateral). Knees were assessed for the presence
(any pain in the past 30 days) and severity (MOST only using visual
analog scale (VAS); 0-100) of knee pain. Using separate logistic regres-
sion models, we determined the relation of full-thickness cartilage loss
and BMLs in each PFJ region with prevalent knee pain. We then com-
pared the differences in VAS pain severity among PFJ regions using
quantile regression (VAS pain scores were not normally distributed).
Analyses were adjusted for age, sex, BMI, and concurrent structural
damage in the tibiofemoral joint (TFJ). We repeated these analyses using
WORMS >1 for BMLs and removing knees with TFJ damage.
Results: 1138 and 949 knees (one knee per subject) from MOST and
FOA, respectively, had MRIs read and knee pain assessments. In MOST,
the mean (sd) age and BMI was 68.9 (7.5) and 29.3 (4.7), respectively;
63.8% female. In FOA, the mean (sd) age and BMI was 63.4 (8.8) and 28.6
(5.6); 57.2% female. The prevalence of knee pain was 55.4% in MOST and
36.4% in FOA. Compartment associations with knee pain were not
consistent across the two studies, although mixed disease was sig-
niﬁcantly associated with pain with each deﬁnition of structural path-
ology. In MOST, full-thickness cartilage loss in the medial PFJ was less
strongly associated with knee pain than was lateral PFJ structural
damage, while neither compartment individually was associated with
pain when involvement was deﬁned by BMLs (Table 1). Furthermore,
the results of the quantile regression demonstrated that knee pain
severity scores were greatest among knees with isolated lateral PFJ
structural damage across a range of pain severity quantiles (Table 2),and lateral patellofemoral joint
Bone Marrow Lesion (WORMS >0)
5%Cl) n of painful knees/ N of knees(%) Adjusted OR** (95%Cl)
210/421 (49.9) Reference
139/255 (54.5) 1.1 (0.8-1.5)
91/150 (60.7) 1.4 (0.9-2.0)
190/312 (60.9) 1.4 (1.0-1.9)
171/573 (30.0) Reference
67/157 (42.7) 1.6 (1.1-2.3)
24/61 (39.3) 1.3(0.8-2.3)
83/158 (52.5) 2.2(1.5-3.2)
FJ BMLs instead of cartilage loss.
the medial and lateral patellofemoral joint in the MOST cohort
Bone Marrow Lesions** (WORMS >0)
entile# 40th Percentile# 50th Percentile# 6th Percentile#
0 0 0
-0.6) 0.1 (-0.6-0.9) 0.4 (-0.8-1.5) 1.1 (-0.8-2.9)
0) 3.3 (1.0-5.6) 3.2 (0.5-5.8) 6.6 (1.7-11.5)
.8) 1.6 (0.4-2.9) 3.1 (1.2-4.9) 3.4 (1.4-5.4)
40th, 50th, and 60th percentiles only as there were too few subjects/data points in the
